Micro Imaging Technology, Inc. (MMTC) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerMicro Imaging Technology, Inc. (MMTC) trades at $0.0001. Micro Imaging Technology, Inc. is a development-stage company focused on fluid monitoring systems for food safety and clinical applications. They are currently developing a laser-based rapid microbial identification system. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for MMTC: MMTC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Micro Imaging Technology, Inc. (MMTC) Healthcare & Pipeline Overview
Micro Imaging Technology, Inc. focuses on developing rapid microbial identification systems for food safety and clinical industries. Their laser-based technology aims to improve pathogen detection, positioning them within the competitive medical devices market, but they face challenges common to early-stage companies in securing funding and navigating regulatory hurdles.
What Is the Investment Thesis for MMTC?
Micro Imaging Technology, Inc. presents a high-risk, high-reward investment opportunity. The company's laser-based rapid microbial identification system targets a significant need for faster pathogen detection in the food safety and clinical sectors. A successful product launch could drive substantial revenue growth. However, the company's limited financial resources, small employee base, and dependence on ongoing research and development pose significant risks. The collaboration with Northern Michigan University is a positive sign, but the company's ability to secure additional funding, navigate regulatory approvals, and compete with established players in the medical devices market remains uncertain. Investors should carefully consider the company's early stage of development and the speculative nature of its future prospects. The negative P/E ratio and substantial Beta of -101.77 reflect the high volatility and uncertainty associated with this stock.
Based on FMP financials and quantitative analysis
MMTC Key Highlights
Micro Imaging Technology, Inc. is developing a laser-based rapid microbial identification system.
- The company is collaborating with Northern Michigan University to improve pathogen sample preparation.
- The company targets the food safety and clinical industries.
- The company has a market capitalization of $0.00B, reflecting its early stage of development.
- The company's Beta is -101.77, indicating high volatility.
Who Are MMTC's Competitors?
MMTC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BJDX Bluejay Diagnostics, Inc. | $0.56 | -4.26% | 30 5-pillar | |
| HYPD Hyperion DeFi, Inc. | $2.85 | +1.79% | $42.4M | 35 5-pillar |
| SNWV SANUWAVE Health, Inc. | $5.07 | -2.87% | $44.9M | 36 5-pillar |
| SRTS Sensus Healthcare, Inc. | $2.82 | -4.41% | $48.6M | 32 5-pillar |
| LNSR LENSAR, Inc. | $5.96 | -1.81% | $73.7M | 43 5-pillar |
| APYX Apyx Medical Corporation | $2.46 | +3.80% | $99.8M | 33 5-pillar |
| MXCT MaxCyte, Inc. | $1.51 | +7.86% | $155M | 31 5-pillar |
| INGN Inogen, Inc. | $7.08 | -0.28% | $188M | 37 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MMTC's Key Strengths?
Developing innovative laser-based microbial identification technology.
- Collaboration with Northern Michigan University.
- Potential for rapid and accurate results.
- Focus on growing food safety and clinical diagnostics markets.
What Are MMTC's Weaknesses?
Early stage of development.
- Limited financial resources.
- Small employee base.
- Dependence on ongoing research and development.
What Are the Key Risks for MMTC?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Limited financial resources and small employee base.
- Competition from established players in the medical devices market.
- Regulatory hurdles and delays in obtaining approvals.
- Technological obsolescence.
- Dependence on ongoing research and development.
What Are MMTC's Competitive Advantages?
- Proprietary laser-based microbial identification technology.
- Collaboration with Northern Michigan University for research and development.
- Potential for faster and more accurate results compared to traditional methods.
What Does MMTC Do?
Micro Imaging Technology, Inc., originally incorporated as Electropure, Inc. in 1979, rebranded in November 2005 to reflect its focus on micro imaging technology. Headquartered in San Clemente, California, the company is dedicated to the development of fluid monitoring systems for both food safety and clinical applications. Their primary focus is a laser-based rapid microbial identification system designed to quickly identify pathogenic bacteria. This system aims to provide faster and more accurate results compared to traditional methods, addressing a critical need in both industries. Currently, Micro Imaging Technology is collaborating with Northern Michigan University to refine a pathogen sample preparation method that could potentially reduce specimen test turnaround time to approximately 4 to 5 hours. This collaboration highlights the company's commitment to innovation and efficiency in microbial detection. As a small company with 5 employees, Micro Imaging Technology is in the early stages of commercializing its technology and faces the challenges associated with bringing a novel medical device to market.
What Products and Services Does MMTC Offer?
- Develop fluid monitoring systems.
- Focus on food safety applications.
- Focus on clinical applications.
- Develop laser-based rapid microbial identification systems.
- Aim to identify pathogenic bacteria quickly.
- Collaborate with universities for research and development.
How Does MMTC Make Money?
- Developing and selling rapid microbial identification systems.
- Targeting food safety and clinical industries.
- Collaborating with research institutions for technology development.
What Industry Does MMTC Operate In?
Micro Imaging Technology, Inc. operates within the medical device industry, specifically targeting the market for rapid microbial identification systems. This market is driven by increasing concerns about foodborne illnesses, hospital-acquired infections, and the need for faster diagnostic tools. The competitive landscape includes established players offering traditional microbial testing methods, as well as emerging companies developing innovative technologies. Micro Imaging Technology aims to differentiate itself through its laser-based system, promising faster and more accurate results. However, the company faces competition from larger, more established companies with greater resources and broader market reach.
Who Are MMTC's Key Customers?
- Food processing companies.
- Clinical laboratories.
- Hospitals.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an unknown, not an operating company
Financial Health
Micro Imaging Technology, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Key Financial Metrics
Return on equity for Micro Imaging Technology, Inc. stands at 115.5%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.06 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
Micro Imaging Technology, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Irvine, US. The company is led by CEO Victor A. Hollander. MMTC has traded publicly since 2000.
MMTC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Developing innovative laser-based microbial identification technology.
- Collaboration with Northern Michigan University.
- Potential for rapid and accurate results.
- Focus on growing food safety and clinical diagnostics markets.
Bear Case
- Early stage of development.
- Limited financial resources.
- Small employee base.
- Dependence on ongoing research and development.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MMTC Latest News
No recent news available for MMTC.
MMTC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MMTC.
Price Targets
Wall Street price target analysis for MMTC.
MMTC MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MMTC; grades run from A+ (80-100) to F (below 30).
Leadership: Victor A. Hollander
CEO
Victor A. Hollander serves as the CEO of Micro Imaging Technology, Inc. His background includes managing small teams and guiding early-stage companies. While detailed information on his prior roles and education is limited, his leadership is focused on driving the development and commercialization of the company's laser-based microbial identification system. He is responsible for overseeing the company's collaboration with Northern Michigan University and securing funding for ongoing research and development.
Track Record: As CEO, Victor A. Hollander has overseen the development of the company's laser-based rapid microbial identification system and the collaboration with Northern Michigan University. His tenure has been focused on advancing the technology and seeking opportunities for commercialization. However, specific milestones and achievements are not publicly available due to the company's early stage of development.
MMTC OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Micro Imaging Technology, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may be subject to less regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and potential for fraud or manipulation.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or scams.
- Lack of regulatory oversight.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Check for any regulatory actions or legal proceedings.
- Collaboration with Northern Michigan University.
- Development of a novel technology.
- Focus on addressing a real-world problem.
- Company has been in business since 1979.
- Headquartered in the United States.
Micro Imaging Technology, Inc. Healthcare Stock: Key Questions Answered
What are the main risks for MMTC?
Micro Imaging Technology, Inc. faces several risks typical of early-stage companies in the medical device industry. These include the risk of failing to secure additional funding to support ongoing research and development, the risk of encountering regulatory hurdles and delays in obtaining approvals for their technology, and the risk of competition from larger, more established players with greater resources.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is limited due to the company's OTC listing and limited public disclosures.
- Financial data is based on available information and may not be comprehensive.